dyqik wrote: Sun Aug 04, 2024 5:37 pm
Withholding puberty blockers from gender dysphoric teenagers increases the risk of suicide substantially.
I think you missed this topic, which reported the news that a government-appointed expert debunked this claim?
viewtopic.php?f=10&t=4272
It's such a toxic area it is hard to know who to believe, and "government-appointed" is not a neutral designation in the present circumstances. But flicking through their report, it was at least quite clear that the claim of increased suicides was anecdata from a small number of data points, not an analysis. Though with the Tavistock shutting down any comment on the issue, it was easy to believe a cover-up was going on. An analysis of the actual data found no such effect. But statistics is tricky stuff, so a peer review would be advisable. At the moment, being unaware of a debunking of this debunking, or credible claim that it is a cover-up, I'm inclined to think this is the best available evidence on this topic, until someone points me elsewhere.
The basic criterion ought to be "first, do no harm", especially in this area of limited evidence. Suicide risk is only one kind of harm. The BBC TV programme on Tavistock Clinic/GIDS
this iplayer link I think, seemed to indicate some other kinds of potential harm from puberty blockers when used for gender dysphoria, for example that there could be some loss of fertility. But searching for evidence on this repeatedly confirms that when used properly and not for too long, and without confounding issues, there is very low risk of any such downsides.
So for me, it increasingly looks like allowing the puberty blockers is the nearer approximation to the "first, do no harm" approach on present evidence, even though it appears that the suicide risk claim was not well founded. Though you still then have to make good decisions in the time window that gives you. If you can't do that, then there's not much point to it. And, as I said before, even Cass didn't go so far as to recommend a ban on puberty blockers for gender dysphoria until there is better evidence, though what she did say wasn't so far short of that. Cass is being attacked from both sides. This topic started with attacks from the right for not going far enough. Now it is being attacked from the other side for going too far. One thing that BMA says is sensible, Cass could do with a peer review. But it is very difficult finding well-informed people who don't already have a particular stance on these matters to do that in an objective way.
The BBC programme I mentioned above had an interview with a woman who had detransitioned after a double mastectomy. She was understandably very bitter about the treatment she got from the Tavistock clinic. She also the fact that they cease supporting you once you detransition, when in fact you need a lot of support at that point. That was exceedingly distressing to watch. This was placed alongside a very happy subject who was very happy with their transition. It seems to be hard to get any good statistics on frequency of the two kinds of outcome. In any area of medicine there are mistakes. Ideally we avoid the former kind of mistake. But we have to choose the option that produces the best overall outcome, recognising that there might be some mistakes.
On Monday, I shall have an operation on my left eye. It might do no good, in which case I shall go through a lot of suffering for nothing. In rare cases, it can do harm. But the operation is indicated because on balance it is the best thing to do with that particular condition in the eye. A decision perfectly separating good from harm is unavailable, we can only go with the balance of advantage. We need to remember that.